JAN 17, 2021 8:03 AM PST

Analyzing the role of our circadian clocks in prostate cancer

Research published recently in Nature Communications looks into the role that circadian rhythms play on prostate cancer progression. The study from Sidney Kimmel Cancer - Jefferson Health (SKCC) focuses specifically on a gene called CRY-1, which is known to be a gene associated with our circadian clocks.

"When we analyzed human cancer data, the circadian factor CRY-1 was found to increase in late-stage prostate cancers, and is strongly associated with poor outcomes," explains senior author Karen Knudsen, MBA PhD. "However, the role CRY-1 in human cancers has not been explored."

In their investigations, the researchers saw that CRY-1 was related to prostate cancer by way of its connection to androgen receptors. Prostate tumors need androgens in order to grow and evolve, which is why the most common treatment for prostate cancer is androgen suppression.

"This was a clear indication of CRY-1's link to prostate cancer," says first author Ayesha Shafi, PhD. "As we looked further into the role of CRY1, we unexpectedly found that the circadian factor was altering the way that cancer cells repair DNA." The authors say that by way of this mechanism, CRY-1 may be protecting cancer cells from therapies aimed to damage tumors.

This finding suggests that CRY-1 could be a therapeutic target for new drug development. "The fact that CRY-1 is elevated in late-stage prostate cancer may explain why androgen-targeting treatments become ineffective at those later stages," explains Dr. Shafi. "It also tells us that if a tumor has high levels of CRY-1, DNA repair targeting treatments may be less effective for them."

Dr. Knudsen adds: "Not only have we outlined a role for CRY-1 outside of its canonical function in circadian rhythms, but Dr. Shafi's findings are also the first to reveal the means by which CRY1 contributes to aggressive disease. It's notable that the pro-tumor functions of CRY1 may be viable targets to treat prostate cancer, and this is a direction that Dr. Shafi's future work will explore. It's been shown that circadian disruptions can affect the efficacy of treatment, but also that aligning treatment with the body's natural rhythms or giving therapy at certain times of the day can be beneficial. Our findings open up a multitude of important research questions exploring the link between the circadian clock and cancer."

Photo: Pexels

Sources: Nature CommunicationsEureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 30, 2020
Cancer
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
NOV 30, 2020
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
Many take modern surgeons and surgical methods for granted. In the grand scheme of things, it wasn’t too long ago ...
NOV 29, 2020
Cell & Molecular Biology
Engineering 'Smart' Cells to Kill Cancer
NOV 29, 2020
Engineering 'Smart' Cells to Kill Cancer
Cancer researchers have long been searching for a way to target cancer cells while ignoring healthy cells. A team of sci ...
DEC 15, 2020
Cancer
New combination therapy may help patients with treatment resistance
DEC 15, 2020
New combination therapy may help patients with treatment resistance
New research from scientists at the UCLA Jonsson Comprehensive Cancer Center showcases a novel combination therapy that ...
DEC 20, 2020
Cell & Molecular Biology
Chromatin Doesn't Behave Like a Liquid or Solid - It's a Gel
DEC 20, 2020
Chromatin Doesn't Behave Like a Liquid or Solid - It's a Gel
A cell's nucleus has to hold the entire genome. To do that, the DNA has to be carefully arranged and compacted by protei ...
JAN 05, 2021
Cancer
Two gene expression subtypes identified in peritoneal carcinomatosis cells
JAN 05, 2021
Two gene expression subtypes identified in peritoneal carcinomatosis cells
New research published in Nature Medicine finds two subtypes of gene expression in peritoneal carcinomatosis (PC) that c ...
JAN 11, 2021
Cancer
Sentinel Nodes Could Reveal a Tumor's Prognosis
JAN 11, 2021
Sentinel Nodes Could Reveal a Tumor's Prognosis
For many diseases, the ability to quickly and effectively diagnose or prognose a patient is critical. If caught early on ...
Loading Comments...